Udder Health Market Size, Share & Trends by Product (Pharmaceuticals, Devices, Supplements), Veterinary Care Settings, Animal Type - Global Forecast to 2029
세계 유방 건강 시장 규모는 5.9%의 CAGR로 확대되어 2024년 12억 달러에서 2029년 16억 달러에 달할 것으로 예측됩니다.
세계 유방 건강 시장에 진출한 기업들은 세계 발자국을 확장하고 시장 점유율을 확대하기 위해 계약, 매각, 확장, 인수 등 다양한 전략을 채택하고 있습니다.
| 조사 범위 |
| 조사 대상 연도 |
2021-2029년 |
| 기준 연도 |
2023년 |
| 예측 기간 |
2024-2029년 |
| 검토 단위 |
금액(10억 달러) |
| 부문 |
제품별, 동물 의료 환경별, 동물 유형별, 질병 유형별, 지역별 |
| 대상 지역 |
북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카 |
유방 건강 시장에서 유두 분무기, 유두 침지 어플리케이터, 유질 분석기, 유방염 검출기 등 기기의 사용이 확대됨에 따라 기기 분야가 두 번째 점유율을 차지했습니다. 이러한 기기는 젖소 유방의 건강 유지에 중요한 역할을 하며, 감염을 예방하고 우유 품질을 보장합니다. 낙농가들은 낙농 생산 효율과 동물 복지 기준을 개선하기 위해 이러한 도구를 점점 더 많이 채택하고 있습니다. 이러한 수요 증가는 이러한 장비의 정확성과 효율성을 향상시키는 기술 발전에 힘입어 현대 낙농 경영에 필수적인 요소로 자리 잡고 있습니다.
동물 의료 환경 유형별로는 낙농 부문이 유방 건강 시장에서 가장 빠른 성장률을 보이고 있습니다. 이는 주로 중소 규모의 낙농장이 수동 착유에서 기계화 착유 시스템으로 점차 전환하고 있기 때문입니다. 이러한 전환은 유방염과 같은 감염 위험을 줄이고 보다 일관되고 위생적인 착유 과정을 보장함으로써 유방 건강을 개선하는 데 도움이 됩니다. 그 결과, 이들 낙농장은 고품질 우유를 생산할 수 있게 되었고, 이는 이 부문의 급격한 성장을 견인하고 있습니다.
동물 유형별로는 젖소 부문이 유방 건강 시장에서 가장 큰 시장 점유율을 차지했는데, 이는 우유와 유제품에 대한 수요가 증가하고 있기 때문입니다. 젖소는 우유 생산에 필수적이며 유방 건강은 안정적인 공급을 위해 필수적입니다. 낙농가들은 고품질 우유 생산을 보장하기 위해 젖소를 건강하게 유지하는 데 주력하고 있으며, 이는 유방 건강 제품 및 서비스 시장을 주도하고 있습니다. 이 부문의 우위는 우유 및 유제품에 대한 세계 수요 증가에 대응하기 위해 업계가 젖소의 건강 유지에 중점을 두고 있음을 반영합니다.
이 보고서는 세계 유방 건강 시장을 조사하여 제품별, 동물 의료 환경별, 동물 유형별, 질병 유형별, 지역별 동향, 시장 진입 기업 개요 등을 정리했습니다.
목차
제1장 소개
제2장 조사 방법
제3장 주요 요약
제4장 주요 인사이트
제5장 시장 개요
- 소개
- 시장 역학
- 업계 동향
- 밸류체인 분석
- 기술 분석
- Porter's Five Forces 분석
- 규제 상황
- 특허 분석
- 무역 분석
- 가격 분석
- 상환 분석
- 주요 회의와 이벤트(2024-2025년)
- 주요 이해관계자와 구입 기준
- 유방 건강 시장의 미충족 수요/최종사용자 기대
- 생태계 분석
- 사례 연구 분석
- 공급망 분석
- 인접 시장
- 고객의 비즈니스에 영향을 미치는 동향/혼란
- 투자와 자금 조달 시나리오
제6장 유방 건강 시장, 제품별
제7장 유방 건강 시장, 동물 의료 환경별
제8장 유방 건강 시장, 동물 유형별
제9장 유방 건강 시장, 질환 유형별
제10장 유방 건강 시장, 지역별
- 소개
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
제11장 경쟁 상황
- 개요
- 주요 진출 기업 전략/비책
- 매출 분석
- 시장 점유율 분석
- 기업 평가 매트릭스 : 주요 진출 기업, 2023년
- 기업 평가 매트릭스 : 스타트업/중소기업, 2023년
- 기업 가치 평가와 재무 지표
- 주요 기업 연구개발비
- 브랜드/제품 비교
- 경쟁 시나리오
제12장 기업 개요
- 주요 진출 기업
- VETOQUINOL S.A.
- ZOETIS INC.
- MERCK & CO., INC.
- VIRBAC
- ECOLAB
- BOEHRINGER INGELHEIM INTERNATIONAL GMBH
- ELANCO ANIMAL HEALTH INCORPORATED
- DELAVAL
- ORFFA
- AHV INTERNATIONAL B.V.
- BOUMATIC LLC
- GEA GROUP AKTIENGESELLSCHAFT
- G SHEPHERD ANIMAL HEALTH
- CEVA SANTE ANIMALE
- 기타 기업
- ALBERT KERBL GMBH
- AMBIC EQUIPMENT LIMITED
- LELY
- ZENEX ANIMAL HEALTH INDIA PRIVATE LTD.
- DRAMINSKI S. A.
- RING BIOTECHNOLOGY CO LTD.
- NICOSIA BIOLABS INTERNATIONAL PRIVATE LIMITED
- BLACKMANGO HERBS
- KORU DIAGNOSTICS LTD.
- MASTAPLEX
- ARBROWN CO., JP LTD.
제13장 부록
ksm
The global udder health market is projected to reach USD 1.6 billion by 2029 from USD 1.2 billion in 2024 at a CAGR of 5.9%. The competitive landscape includes the analysis of the key growth strategies adopted by major players between January 2020 and May 2024. Players in the global udder health market have employed various strategies to expand their global footprint and increase their market shares such as agreements, divestitures, expansions, and acquisitions.
| Scope of the Report |
|---|
| Years Considered for the Study | 2021-2029 |
| Base Year | 2023 |
| Forecast Period | 2024-2029 |
| Units Considered | Value (USD Billion) |
| Segments | Product, Veterinary Care Setting, Animal Type, and Disease Type |
| Regions covered | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
"The Devices segment accounted the second-largest market share in the udder health market."
In the udder health market, the Devices segment holds the second-largest share because of the growing use of equipment like teat sprayers, teat dip applicators, milk quality analyzers, and mastitis detectors. These devices play a crucial role in maintaining the health of dairy cow udders by preventing infections and ensuring milk quality. Farmers increasingly adopt these tools to improve dairy production efficiency and animal welfare standards. The rise in demand is fueled by advancements in technology that enhance the accuracy and effectiveness of these devices, making them indispensable in modern dairy farm operations.
"Dairy farms segment of the udder health market is expected to witness the fastest CAGR."
By veterinary care setting type, the dairy farms segment has witnessed the fastest growth rate in the udder health market. This is largely because small and medium-scale dairy farms are gradually switching from manual milking to mechanized milking systems. This transition helps improve udder health by reducing the risk of infections like mastitis, ensuring more consistent and hygienic milking processes. As a result, these farms are better able to produce high-quality milk, which drives the segment's rapid growth.
"The Dairy cattle segment of the udder health market accounted for the largest market share."
Based on animal type, the dairy cattle segment accounted for the largest market share in the udder health market because of growing demand for milk and milk products. Dairy cattles are crucial for milk production, making their udder health vital for consistent supply. Farmers focus on keeping their cows healthy to ensure high-quality milk production, which drives the market for udder health products and services. This segment's dominance reflects the industry's emphasis on maintaining cow health to meet the rising global demand for milk and dairy products.
"Clinical mastitis segment of the udder health market is expected to witness the fastest CAGR."
By disease type, the clinical mastitis has experienced the fastest CAGR, in the udder health market, due to rising cases of mastitis and other related issue. The increasing prevalence of this disease has driven demand for effective treatments and management solutions within the market. As dairy farms strive to maintain herd health and productivity, there's a growing emphasis on products and practices that can prevent and treat mastitis effectively, contributing to the segment's rapid growth in the udder health industry.
"North America to have the second largest market share in the udder health market during the forecast period."
North America holds the second largest share in the udder health market. This is mainly because farmers in this region have higher incomes, allowing them to invest more in the health and care of their dairy cows. As their earnings grow, they can afford better products and services to maintain the udder health of their livestock. This increase in spending power boosts the market, making North America a significant player in this sector.
A breakdown of the primary participants (supply side) for the udder health market referred to for this report is provided below:
- By Company Type: Tier 1-35%, Tier 2-25%, and Tier 3-40%
- By Designation: C-level-45%, Director Level-25%, and Others-30%
- By Region: North America-36%, Europe-26%, Asia Pacific-21%, Latin America-10%, and Middle East & Africa_ 7%
A breakdown of the primary participants (demand side) for the udder health market refer to for the report is provided below:
- By Veterinary Care Setting Type: Dairy Farms-65%, Veterinary Hospitals and Clinics-35%
- By Designation: Farm Owners-55%, Veterinarians-45%
- By Region: North America-34%, Europe-27%, Asia Pacific-23%, Latin America-9%, and Middle East & Africa-7%
Key Market Players:
The prominent players in the udder health market include Vetoquinol S.A. (France), Zoetis Inc. (US), Merck & Co., Inc. (US), Virbac (France), Ecolab (US), Boehringer Ingelheim GmbH (Germany), Elanco Animal Health Incorporated (US), DeLaval (Sweden), Orffa (Netherlands), AHV International (Netherlands), Boumatic LLC (US), GEA Group Aktiengesellschaft (Germany), G Shepherd Animal Health (UK), Ceva Sante Animale (France), Albert Kerbl GmbH (Germany), Ambic Equipment Limited (England), Lely (Netherlands), Zenex Animal Health India Private Limited (India), Draminski S.A. (Poland), Ring Biotechnology Co Ltd. (China), Nicosia Biolabs International Private Limited (India), Blackmango Herb (India), Koru Diagnostics Ltd. (New Zealand), Mastaplex (New Zealand), and AR Brown Co., Ltd. (Japan).
Research Coverage:
The market analysis examines the udder health market in numerous segments. It seeks to estimate the market size and growth potential across many segments, including product, veterinary care setting, animal type, disease type and geography. The study also includes a detailed competitive analysis of the market's top competitors, as well as company profiles, significant insights about their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The study will assist industry leaders/new entrants in this market by providing information on the closest approximations of the udder health market and its segments. This research will assist stakeholders understand the competitive landscape, obtaining insights to better position their firms, and developing appropriate go-to-market strategies. The study will also assist stakeholders in understanding the market pulse and obtaining information on major market drivers, constraints, opportunities, and challenges.
This report provides insights into the following pointers:
- Analysis of key Drivers: Drivers (Increasing Demand of Milk and Dairy Products, Increasing number of veterinary practitioner in developed economies, Increasing Incidence of Mastitis and Other Udder Health Disorders, Technological Advancements in Udder Health Monitoring), Restrains (Lack of Awareness and Education Among Small-Scale Dairy Farmers), Opportunities (Gradual transitions of small and medium-scale dairy farms from manual milking to mechanized milking solutions, Increasing per capita income of farmers in developing countries), Challenges (Regulatory control on livestock industry to reduce outbreak of diseases) influencing the growth of the udder health market.
- Market Penetration: Comprehensive information on the product portfolios of the leading companies in the udder health market. The report breaks down the market by product type, veterinary care setting types, animal types, disease types and region.
- Product Enhancement/Innovation: Detailed information about forthcoming trends and product launches in the udder health market.
- Market Development: Comprehensive data on attractive rising markets broken down by product category, veterinary care setting types, animal types, disease types and region.
- Market Diversification: Comprehensive information on new products, expanding geographies, current advancements, and investments in the udder health market.
- Competitive Assessment: In-depth analysis of market share, growth strategies, product and service offerings, and capabilities of the main udder health products manufacturers.
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.2.1 INCLUSIONS & EXCLUSIONS
- 1.2.2 MARKET SCOPE
- 1.2.3 YEARS CONSIDERED
- 1.2.4 CURRENCY CONSIDERED
- 1.3 STAKEHOLDERS
- 1.4 RECESSION IMPACT
2 RESEARCH METHODOLOGY
- 2.1 RESEARCH DATA
- 2.2 RESEARCH METHODOLOGY DESIGN
- 2.2.1 SECONDARY DATA
- 2.2.1.1 Key data from secondary sources
- 2.2.2 PRIMARY DATA
- 2.2.2.1 Key data from primary sources
- 2.2.2.2 Key industry insights
- 2.3 MARKET SIZE ESTIMATION
- 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
- 2.5 MARKET SHARE ESTIMATION
- 2.6 STUDY ASSUMPTIONS
- 2.7 RESEARCH LIMITATIONS
- 2.7.1 METHODOLOGY-RELATED LIMITATIONS
- 2.7.2 SCOPE-RELATED LIMITATIONS
- 2.8 RISK ASSESSMENT
- 2.9 RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
- 4.1 UDDER HEALTH MARKET OVERVIEW
- 4.2 ASIA PACIFIC: UDDER HEALTH MARKET, BY PRODUCT AND COUNTRY (2023)
- 4.3 UDDER HEALTH MARKET: REGIONAL MIX
- 4.4 UDDER HEALTH MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW
- 5.1 INTRODUCTION
- 5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
- 5.2.1.1 Increasing demand for milk & dairy products
- 5.2.1.2 Rising incidence of mastitis
- 5.2.1.3 Increasing number of veterinary practitioners in developed markets and subsequent focus on preventive health measures
- 5.2.1.4 Technological advancements in udder health monitoring devices
- 5.2.2 RESTRAINTS
- 5.2.2.1 Limited resources and low awareness among small-scale dairy farmers
- 5.2.3 OPPORTUNITIES
- 5.2.3.1 Gradual transition from manual milking to mechanized milking solutions
- 5.2.3.2 Increasing per capita income of farmers in emerging markets
- 5.2.4 CHALLENGES
- 5.2.4.1 Stringent regulatory guidelines for livestock industry
- 5.3 INDUSTRY TRENDS
- 5.3.1 RISING DEMAND FOR ORGANIC UDDER HEALTH PRODUCTS
- 5.3.2 INCREASING R&D ACTIVITIES FOR INNOVATIVE UDDER HEALTH SOLUTIONS
- 5.3.3 EMPHASIS ON SUSTAINABLE PRACTICES
- 5.4 VALUE CHAIN ANALYSIS
- 5.5 TECHNOLOGY ANALYSIS
- 5.5.1 KEY TECHNOLOGIES
- 5.5.1.1 Telemedicine
- 5.5.1.2 AI integration in udder health
- 5.5.2 COMPLEMENTARY TECHNOLOGIES
- 5.5.2.1 Nutritional supplements
- 5.5.2.2 Integration of barn environmental management system
- 5.5.3 ADJACENT TECHNOLOGIES
- 5.5.3.1 Precision livestock farming
- 5.5.3.2 Integration of cattle & livestock management software
- 5.6 PORTER'S FIVE FORCES ANALYSIS
- 5.6.1 THREAT OF NEW ENTRANTS
- 5.6.2 BARGAINING POWER OF SUPPLIERS
- 5.6.3 BARGAINING POWER OF BUYERS
- 5.6.4 THREAT OF SUBSTITUTES
- 5.6.5 COMPETITIVE RIVALRY
- 5.7 REGULATORY LANDSCAPE
- 5.7.1 REGULATORY ANALYSIS
- 5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.8 PATENT ANALYSIS
- 5.8.1 PATENT PUBLICATION TRENDS FOR UDDER HEALTH MARKET
- 5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
- 5.9 TRADE ANALYSIS
- 5.9.1 TRADE ANALYSIS FOR UDDER HEALTH PRODUCTS
- 5.10 PRICING ANALYSIS
- 5.10.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TYPE
- 5.10.2 AVERAGE SELLING PRICE TREND OF UDDER HEALTH PRODUCTS, BY REGION
- 5.11 REIMBURSEMENT ANALYSIS
- 5.12 KEY CONFERENCES AND EVENTS (2024-2025)
- 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
- 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.13.2 BUYING CRITERIA
- 5.14 UNMET NEEDS/END-USER EXPECTATIONS IN UDDER HEALTH MARKET
- 5.15 ECOSYSTEM ANALYSIS
- 5.16 CASE STUDY ANALYSIS
- 5.16.1 EARLY MASTITIS DETECTION WITH SENSOR TECHNOLOGY
- 5.16.2 AUTOMATION OF PRE-TEAT DIPPING FOR HIGH EFFICIENCY
- 5.16.3 UTILIZING HERD MANAGEMENT SOFTWARE FOR DATA-DRIVEN DECISIONS
- 5.17 SUPPLY CHAIN ANALYSIS
- 5.18 ADJACENT MARKETS
- 5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- 5.20 INVESTMENT & FUNDING SCENARIO
6 UDDER HEALTH MARKET, BY PRODUCT
- 6.1 INTRODUCTION
- 6.2 DEVICES
- 6.2.1 MILK QUALITY ANALYZERS
- 6.2.1.1 Ability to ensure quality & safety to drive market
- 6.2.2 MILK SAMPLING EQUIPMENT
- 6.2.2.1 Growing demand for automated sampling systems and manual sampling kits to drive market
- 6.2.3 MILK MANAGEMENT SYSTEMS
- 6.2.3.1 Rising technological advancements to support market growth
- 6.2.4 OTHER UDDER HEALTH DEVICES
- 6.3 PHARMACEUTICALS
- 6.3.1 ANTIBIOTICS
- 6.3.1.1 Advancements in formulations and delivery methods to propel market
- 6.3.2 VACCINES
- 6.3.2.1 Growth in dairy farm sector to boost demand
- 6.3.3 ANTI-INFLAMMATORY DRUGS
- 6.3.3.1 Innovative product launches to support market growth
- 6.3.4 INTRAMAMMARY INFUSIONS
- 6.3.4.1 Ability to provide targeted treatment during dry season to drive market
- 6.3.5 TEAT SEALANTS
- 6.3.5.1 Antimicrobial properties to drive market
- 6.3.6 OTHER UDDER HEALTH PHARMACEUTICALS
- 6.4 SUPPLEMENTS
- 6.4.1 VITAMINS & MINERALS
- 6.4.1.1 Essential requirement for optimal health of dairy cattle to fuel uptake
- 6.4.2 PROBIOTICS & PREBIOTICS
- 6.4.2.1 Growing demand for nutraceuticals to drive market
- 6.4.3 OTHER UDDER HEALTH SUPPLEMENTS
7 UDDER HEALTH MARKET, BY VETERINARY CARE SETTING
- 7.1 INTRODUCTION
- 7.2 DAIRY FARMS
- 7.2.1 GROWING DEMAND FOR MILK & DAIRY PRODUCTS TO DRIVE MARKET
- 7.3 VETERINARY HOSPITALS AND CLINICS
- 7.3.1 INCREASING ESTABLISHMENT OF CLINICAL PRACTICES ACROSS EMERGING ECONOMIES TO SUPPORT MARKET GROWTH
8 UDDER HEALTH MARKET, BY ANIMAL TYPE
- 8.1 INTRODUCTION
- 8.2 DAIRY CATTLE
- 8.2.1 GROWTH IN CATTLE POPULATION TO DRIVE MARKET
- 8.3 OTHER ANIMAL TYPES
9 UDDER HEALTH MARKET, BY DISEASE TYPE
- 9.1 INTRODUCTION
- 9.2 CLINICAL MASTITIS
- 9.2.1 INCREASING PREVALENCE AND HIGH COSTS ASSOCIATED WITH TREATMENT TO PROPEL MARKET
- 9.3 OTHER DISEASE TYPES
10 UDDER HEALTH MARKET, BY REGION
- 10.1 INTRODUCTION
- 10.2 NORTH AMERICA
- 10.2.1 NORTH AMERICA: RECESSION IMPACT
- 10.2.2 US
- 10.2.2.1 Increasing number of veterinary practitioners to drive market
- 10.2.3 CANADA
- 10.2.3.1 High R&D investments for udder monitoring products to drive market
- 10.3 EUROPE
- 10.3.1 EUROPE: RECESSION IMPACT
- 10.3.2 GERMANY
- 10.3.2.1 Advanced dairy farming practices to fuel uptake
- 10.3.3 UK
- 10.3.3.1 High adoption of advanced veterinary technologies to propel market
- 10.3.4 FRANCE
- 10.3.4.1 Expanding dairy industry to support market growth
- 10.3.5 ITALY
- 10.3.5.1 Growing investments in udder health solutions to drive market
- 10.3.6 SWITZERLAND
- 10.3.6.1 Growing demand for mastitis detectors to fuel uptake
- 10.3.7 SPAIN
- 10.3.7.1 Increasing establishment of dairy farms to boost demand
- 10.3.8 REST OF EUROPE
- 10.4 ASIA PACIFIC
- 10.4.1 ASIA PACIFIC: RECESSION IMPACT
- 10.4.2 JAPAN
- 10.4.2.1 Growing focus on automated milking systems to boost demand
- 10.4.3 CHINA
- 10.4.3.1 Increase in milk consumption to propel market
- 10.4.4 INDIA
- 10.4.4.1 Growing population of dairy cattle to drive market
- 10.4.5 AUSTRALIA
- 10.4.5.1 Stringent dairy farming regulations to propel market
- 10.4.6 SOUTH KOREA
- 10.4.6.1 Increasing awareness and adoption of preventive healthcare measures among dairy farmers to drive market
- 10.4.7 REST OF ASIA PACIFIC
- 10.5 LATIN AMERICA
- 10.5.1 LATIN AMERICA: RECESSION IMPACT
- 10.5.2 BRAZIL
- 10.5.2.1 Emphasis on improving milk quality to boost demand
- 10.5.3 MEXICO
- 10.5.3.1 Improvements in animal welfare standards to support market growth
- 10.5.4 REST OF LATIN AMERICA
- 10.6 MIDDLE EAST & AFRICA
- 10.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT
- 10.6.2 GCC COUNTRIES
- 10.6.2.1 Improvements in economic stability to support market growth
- 10.6.3 REST OF MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
- 11.1 OVERVIEW
- 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN UDDER HEALTH MARKET
- 11.3 REVENUE ANALYSIS
- 11.4 MARKET SHARE ANALYSIS
- 11.4.1 RANKING OF KEY MARKET PLAYERS
- 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
- 11.5.1 STARS
- 11.5.2 EMERGING LEADERS
- 11.5.3 PERVASIVE PLAYERS
- 11.5.4 PARTICIPANTS
- 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
- 11.5.5.1 Company footprint
- 11.5.5.2 Region footprint
- 11.5.5.3 Product footprint
- 11.5.5.4 Veterinary care setting footprint
- 11.5.5.5 Animal type footprint
- 11.5.5.6 Disease type footprint
- 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
- 11.6.1 PROGRESSIVE COMPANIES
- 11.6.2 RESPONSIVE COMPANIES
- 11.6.3 DYNAMIC COMPANIES
- 11.6.4 STARTING BLOCKS
- 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
- 11.7 COMPANY VALUATION AND FINANCIAL METRICS
- 11.7.1 FINANCIAL METRICS
- 11.7.2 COMPANY VALUATION
- 11.8 R&D EXPENDITURE OF KEY PLAYERS
- 11.9 BRAND/PRODUCT COMPARISON
- 11.10 COMPETITIVE SCENARIO
- 11.10.1 PRODUCT LAUNCHES & APPROVALS
- 11.10.2 DEALS
- 11.10.3 EXPANSIONS
- 11.10.4 OTHER DEVELOPMENTS
12 COMPANY PROFILES
- 12.1 KEY PLAYERS
- 12.1.1 VETOQUINOL S.A.
- 12.1.1.1 Business overview
- 12.1.1.2 Products offered
- 12.1.1.3 Recent developments
- 12.1.1.3.1 Deals
- 12.1.1.3.2 Other developments
- 12.1.1.4 MnM view
- 12.1.1.4.1 Key strengths
- 12.1.1.4.2 Strategic choices
- 12.1.1.4.3 Weaknesses & competitive threats
- 12.1.2 ZOETIS INC.
- 12.1.2.1 Business overview
- 12.1.2.2 Products offered
- 12.1.2.3 Recent developments
- 12.1.2.3.1 Product launches
- 12.1.2.3.2 Expansions
- 12.1.2.4 MnM view
- 12.1.2.4.1 Key strengths
- 12.1.2.4.2 Strategic choices
- 12.1.2.4.3 Weaknesses & competitive threats
- 12.1.3 MERCK & CO., INC.
- 12.1.3.1 Business overview
- 12.1.3.2 Products offered
- 12.1.3.3 Recent developments
- 12.1.3.3.1 Product launches & approvals
- 12.1.3.4 MnM view
- 12.1.3.4.1 Key strengths
- 12.1.3.4.2 Strategic choices
- 12.1.3.4.3 Weaknesses & competitive threats
- 12.1.4 VIRBAC
- 12.1.4.1 Business overview
- 12.1.4.2 Products offered
- 12.1.4.3 MnM view
- 12.1.4.3.1 Key strengths
- 12.1.4.3.2 Strategic choices
- 12.1.4.3.3 Weaknesses & competitive threats
- 12.1.5 ECOLAB
- 12.1.5.1 Business overview
- 12.1.5.2 Products offered
- 12.1.5.3 Recent developments
- 12.1.5.3.1 Product launches
- 12.1.5.3.2 Deals
- 12.1.6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
- 12.1.6.1 Business overview
- 12.1.6.2 Products offered
- 12.1.6.3 MnM view
- 12.1.6.3.1 Key strengths
- 12.1.6.3.2 Strategic choices
- 12.1.6.3.3 Weaknesses & competitive threats
- 12.1.7 ELANCO ANIMAL HEALTH INCORPORATED
- 12.1.7.1 Business overview
- 12.1.7.2 Products offered
- 12.1.8 DELAVAL
- 12.1.8.1 Business overview
- 12.1.8.2 Products offered
- 12.1.8.3 Recent developments
- 12.1.8.3.1 Product launches
- 12.1.8.3.2 Other developments
- 12.1.9 ORFFA
- 12.1.9.1 Business overview
- 12.1.9.2 Products offered
- 12.1.9.3 Recent developments
- 12.1.10 AHV INTERNATIONAL B.V.
- 12.1.10.1 Business overview
- 12.1.10.2 Products offered
- 12.1.11 BOUMATIC LLC
- 12.1.11.1 Business overview
- 12.1.11.2 Products offered
- 12.1.12 GEA GROUP AKTIENGESELLSCHAFT
- 12.1.12.1 Business overview
- 12.1.12.2 Products offered
- 12.1.13 G SHEPHERD ANIMAL HEALTH
- 12.1.13.1 Business overview
- 12.1.13.2 Products offered
- 12.1.13.3 Recent developments
- 12.1.13.3.1 Other developments
- 12.1.14 CEVA SANTE ANIMALE
- 12.1.14.1 Business overview
- 12.1.14.2 Products offered
- 12.2 OTHER PLAYERS
- 12.2.1 ALBERT KERBL GMBH: COMPANY OVERVIEW
- 12.2.2 AMBIC EQUIPMENT LIMITED: COMPANY OVERVIEW
- 12.2.3 LELY: COMPANY OVERVIEW
- 12.2.4 ZENEX ANIMAL HEALTH INDIA PRIVATE LTD.: COMPANY OVERVIEW
- 12.2.5 DRAMINSKI S. A.: COMPANY OVERVIEW
- 12.2.6 RING BIOTECHNOLOGY CO LTD.: COMPANY OVERVIEW
- 12.2.7 NICOSIA BIOLABS INTERNATIONAL PRIVATE LIMITED: COMPANY OVERVIEW
- 12.2.8 BLACKMANGO HERBS: COMPANY OVERVIEW
- 12.2.9 KORU DIAGNOSTICS LTD.: COMPANY OVERVIEW
- 12.2.10 MASTAPLEX: COMPANY OVERVIEW
- 12.2.11 ARBROWN CO., JP LTD.: COMPANY OVERVIEW
13 APPENDIX
- 13.1 DISCUSSION GUIDE
- 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 13.3 CUSTOMIZATION OPTIONS
- 13.4 RELATED REPORTS
- 13.5 AUTHOR DETAILS
